Skip to content

Effect of 12 Months Supplementation With a Symbiotic Lozenge on Caries Increment in Healthy Children

Effect of 12 Months Supplementation With a Symbiotic Lozenge on Caries Increment in Healthy Children: A Randomized, Parallel-grouped, Placebo-controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03928587
Acronym
PiP-C
Enrollment
343
Registered
2019-04-26
Start date
2019-05-01
Completion date
2021-10-08
Last updated
2022-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

The primary objective of this trial is to investigate the effect of a symbiotic lozenge on dental caries in young children.

Detailed description

The study is a multicentre, randomized, double-blind, placebo-controlled, parallel-group study in healthy children aged 5-8 years. The objective is to investigate the effect of a symbiotic lozenge on caries increment in primary molar teeth, primary canines and erupted occlusal surfaces at the first permanent molar teeth.The study will take place in Helsingør and Fredensborg municipality. The study consists of a baseline visit prior to a 12 months intervention period, followed by a visit after completion. During the intervention period, two to four months after the baseline visit, a saliva sample will be collected. All guardians to the subjects are encouraged to 1) brush their children's teeth twice daily with the fluoride toothpaste provided, 2) avoid the food provided in appendix D and 3) to continue the subject's dental appointments at local Public Dental Health Service (PDHS). No further specific oral hygiene or dietary instructions/restrictions are provided. Assuming a dropout rate of 12.5%, 175 children will be included in each treatment group.

Interventions

DIETARY_SUPPLEMENT2 billion CFU in total of the two strains Lactobacillus paracasei subsp. paracasei and Lactobacillus rhamnosus and arginine.

One lozenge once daily for 12 months

DIETARY_SUPPLEMENTPlacebo

Placebo once daily for 12 months

Sponsors

University of Copenhagen
CollaboratorOTHER
Chr Hansen
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy children with absence of severe chronic disease 2. Age 5-8 years, both inclusive, at inclusion 3. Ability to cooperate at dental examination 4. Ability to cooperate to a daily intake of a lozenge 5. Parents/legal guarding provided voluntary written informed consent

Exclusion criteria

1. Children with severe medical conditions 2. Mentally or physically disabled children 3. Children of parents with language barriers and not able to give written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Increase in caries incidence12 monthsCaries increment in primary molar teeth, primary canines and erupted occlusal surfaces at the first permanent molar teeth in children aged 5-8 years, using a modified dmf-s scale, including the occlusal surfaces of the first permanent teeth where d is defined by ICDAS scale and assessed both clinically and by dental x-ray.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026